Mark Asquith
Impact in
- Rheumatology top 1%
- Spondyloarthritis Studies and Treatments
- Immunology top 2%
- Immune Cell Function and Interaction
- Psoriasis: Treatment and Pathogenesis
- IL-33, ST2, and ILC Pathways
Papers in
- Rheumatology 13
- Spondyloarthritis Studies and Treatments 10
-
- Dermatology and Skin Diseases 7
- Co-authors
- James T. RosenbaumFiona PowrieLisa KarstensPhoebe LinKevin J. MaloySean DavinBurkhard BecherOliver J. Harrison
- Journals
- Investigative Ophthalmology & Visual Science (6 papers)Arthritis & Rheumatology (5 papers)Current Opinion in Rheumatology (3 papers)The Journal of Experimental Medicine (3 papers)Scientific Reports (2 papers)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Mark Asquith
45 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Rheumatology 837
- Immunology 987
- Ophthalmology 321
- Biological Psychiatry 68
- Periodontics 117
Countries citing papers authored by Mark Asquith
This map shows the geographic impact of Mark Asquith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Asquith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Asquith more than expected).
Fields of papers citing papers by Mark Asquith
This network shows the impact of papers produced by Mark Asquith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Asquith. The network helps show where Mark Asquith may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark Asquith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 19 | |
| 2 | 2020 | 36 | |
| 3 | 2018 | 85 | |
| 4 | 2018 | 17 | |
| 5 | 2018 | 102 | |
| 6 | 2017 | 51 | |
| 7 | The gut microbiome in advanced age-related macular degeneration | 2017 | 6 |
| 8 | 2017 | 107 | |
| 9 | 2016 | 40 | |
| 10 | The role of the gut microbiota in immune-mediated uveitis | 2015 | 3 |
| 11 | 2015 | 32 | |
| 12 | 2015 | 6 | |
| 13 | Altering the gut microbiota ameliorates experimental autoimmune uveitis | 2014 | 6 |
| 14 | 2014 | 81 | |
| 15 | 2014 | 17 | |
| 16 | 2013 | 26 | |
| 17 | IL-1β mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4+ Th17 cells Hit paper breakdown → | 2012 | 470 |
| 18 | 2012 | 47 | |
| 19 | 2010 | 82 | |
| 20 | 2009 | 24 |
About Mark Asquith
Mark Asquith is a scholar working on Rheumatology, Dermatology, Immunology, Ophthalmology and Epidemiology, having authored 45 papers that have together received 3.1k indexed citations. Recurring topics across this work include Gut microbiota and health (18 papers), Inflammatory Bowel Disease (12 papers), Spondyloarthritis Studies and Treatments (10 papers), Mycobacterium research and diagnosis (8 papers), Dermatology and Skin Diseases (7 papers), Immune Cell Function and Interaction (7 papers), Ocular Diseases and Behçet’s Syndrome (5 papers) and Syphilis Diagnosis and Treatment (4 papers). The work is most often cited by research in Rheumatology (837 citations), Immunology (987 citations), Ophthalmology (321 citations), Biological Psychiatry (68 citations) and Periodontics (117 citations). Mark Asquith has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include James T. Rosenbaum, Fiona Powrie, Lisa Karstens, Phoebe Lin, Kevin J. Maloy, Sean Davin, Burkhard Becher, Oliver J. Harrison, Margherita Coccia and Chris Schiering. Their work appears in journals such as Investigative Ophthalmology & Visual Science, Arthritis & Rheumatology, Current Opinion in Rheumatology, The Journal of Experimental Medicine and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.